Platelet-rich plasma intra-articular knee injections show no superiority versus viscosupplementation: A randomized controlled trial

American Journal of Sports Medicine

Volumn 43, Issue 7, 2015, Pages 1575-1582

  Filardo, Giuseppe ^a   Di Matteo, Berardo ^a   Di Martino, Alessandro ^a   Merli, Maria Letizia ^a   Cenacchi, Annarita ^a   Fornasari, Piermaria ^a   Marcacci, Maurilio ^a   Kon, Elizaveta ^a  

^a RIZZOLI ORTHOPAEDIC INSTITUTE   (Italy)

Author keywords

cartilage; growth factors; injections; intra articular; osteoarthritis; PRP; viscosupplementation

Indexed keywords

HYALURONIC ACID;

ADULT; AGED; CARTILAGE DISEASES; COMPARATIVE STUDY; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; INTRAARTICULAR DRUG ADMINISTRATION; JOINT CHARACTERISTICS AND FUNCTIONS; KNEE; KNEE INJURIES; MALE; MIDDLE AGED; OSTEOARTHRITIS, KNEE; PAIN; PAIN MEASUREMENT; PATHOPHYSIOLOGY; PATIENT SATISFACTION; PROCEDURES; RANDOMIZED CONTROLLED TRIAL; THROMBOCYTE RICH PLASMA; TREATMENT OUTCOME; VISCOSUPPLEMENTATION;

ADULT; AGED; CARTILAGE DISEASES; DOUBLE-BLIND METHOD; FEMALE; HUMANS; HYALURONIC ACID; INJECTIONS, INTRA-ARTICULAR; KNEE INJURIES; KNEE JOINT; MALE; MIDDLE AGED; OSTEOARTHRITIS, KNEE; PAIN; PAIN MEASUREMENT; PATIENT SATISFACTION; PLATELET-RICH PLASMA; RANGE OF MOTION, ARTICULAR; TREATMENT OUTCOME; VISCOSUPPLEMENTATION;

EID: 84935042442     PISSN: 03635465     EISSN: 15523365     Source Type: Journal    
DOI: 10.1177/0363546515582027     Document Type: Article

References (37)

1. Anitua E, Sánchez M, Orive G,. Potential of endogenous regenerative technology for in situ regenerative medicine. Adv Drug Deliv Rev. 2010; 62 (7-8): 741-752.
2. Assirelli E, Filardo G, Mariani E,. Effect of two different preparations of platelet-rich plasma on synoviocytes. [published online 19, 2014 ]. Knee Surg Sports Traumatol Arthrosc. doi: 10.1007/s00167-014-3113-3.
3. Bannuru RR, Schmid CH, Kent DM, Vaysbrot EE, Wong JB, McAlindon TE,. Comparative effectiveness of pharmacologic interventions for knee osteoarthritis: a systematic review and network meta-analysis. Ann Intern Med. 2015; 162 (1): 46-54.
4. Braun HJ, Kim HJ, Chu CR, Dragoo JL,. The effect of platelet-rich plasma formulations and blood products on human synoviocytes: implications for intra-articular injury and therapy. Am J Sports Med. 2014; 42 (5): 1204-1210.
5. Cavallo C, Filardo G, Mariani E,. Comparison of platelet-rich plasma formulations for cartilage healing: an in vitro study. J Bone Joint Surg Am. 2014; 96 (5): 423-429.
6. Cerza F, Carnì S, Carcangiu A,. Comparison between hyaluronic acid and platelet-rich plasma, intra-articular infiltration in the treatment of gonarthrosis. Am J Sports Med. 2012; 40 (12): 2822-2827.
7. Cole BJ, Seroyer ST, Filardo G, Bajaj S, Fortier LA,. Platelet-rich plasma: where are we now and where are we going? Sports Health. 2010; 2 (3): 203-210.
8. Di Matteo B, Filardo G, Lo Presti M, Kon E, Marcacci M,. Chronic anti-platelet therapy: a contraindication for platelet-rich plasma intra-articular injections? Eur Rev Med Pharmacol Sci. 2014; 18 (1 suppl): 55-59.
9. Dohan Ehrenfest DM, Bielecki T, Del Corso M, Inchingolo F, Sammartino G,. Shedding light in the controversial terminology for platelet-rich products: platelet-rich plasma (PRP), platelet-rich fibrin (PRF), platelet-leukocyte gel (PLG), preparation rich in growth factors (PRGF), classification and commercialism. J Biomed Mater Res A. 2010; 95 (4): 1280-1282.
10. Dohan Ehrenfest DM, Bielecki T, Jimbo R,. Do the fibrin architecture and leukocyte content influence the growth factor release of platelet concentrates? An evidence-based answer comparing a pure platelet-rich plasma (P-PRP) gel and a leukocyte- and platelet-rich fibrin (L-PRF). Curr Pharm Biotechnol. 2012; 13 (7): 1145-1152.
11. Filardo G, Kon E, Di Matteo B,. Leukocyte-poor PRP application for the treatment of knee osteoarthritis. Joints. 2014; 1 (3): 112-120.
12. Filardo G, Kon E, Di Martino A,. Platelet-rich plasma vs hyaluronic acid to treat knee degenerative pathology: study design and preliminary results of a randomized controlled trial. BMC Musculoskelet Disord. 2012; 13: 229.
13. Filardo G, Kon E, Pereira Ruiz MT,. Platelet-rich plasma intra-articular injections for cartilage degeneration and osteoarthritis: single- versus double-spinning approach. Knee Surg Sports Traumatol Arthrosc. 2012; 20 (10): 2082-2091.
14. Filardo G, Kon E, Roffi A, Di Matteo B, Merli ML, Marcacci M,. Platelet-rich plasma: why intra-articular? A systematic review of preclinical studies and clinical evidence on PRP for joint degeneration. [published online 26, 2014 ]. Knee Surg Sports Traumatol Arthrosc. doi: 10.1007/s00167-013-2743-1.
15. Gobbi A, Lad D, Karnatzikos G,. The effects of repeated intra-articular PRP injections on clinical outcomes of early osteoarthritis of the knee. [published online 20, 2014 ]. Knee Surg Sports Traumatol Arthrosc. doi: 10.1007/s00167-014-2987-4.
16. Gomoll AH, Filardo G, Almqvist FK,. Surgical treatment for early osteoarthritis, part II: allografts and concurrent procedures. Knee Surg Sports Traumatol Arthrosc. 2012; 20 (3): 468-486.
17. Guccione AA, Felson DT, Anderson JJ,. The effects of specific medical conditions on the functional limitations of elders in the Framingham Study. Am J Public Health. 1994; 84 (3): 351-358.
18. Johnson VL, Hunter DJ,. The epidemiology of osteoarthritis. Best Pract Res Clin Rheumatol. 2014; 28 (1): 5-15.
19. Kon E, Filardo G, Di Matteo B, Marcacci M,. PRP for the treatment of cartilage pathology. Open Orthop J. 2013; 7: 120-128.
20. Kon E, Filardo G, Drobnic M,. Non-surgical management of early knee osteoarthritis. Knee Surg Sports Traumatol Arthrosc. 2012; 20 (3): 436-449.
21. Kon E, Mandelbaum B, Buda R,. Platelet-rich plasma intra-articular injection versus hyaluronic acid viscosupplementation as treatments for cartilage pathology: from early degeneration to osteoarthritis. Arthroscopy. 2011; 27 (11): 1490-1501.
22. Lawrence RC, Felson DT, Helmick CG,. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States, part II. Arthritis Rheum. 2008; 58 (1): 26-35.
23. Luyten FP, Denti M, Filardo G, Kon E, Engebretsen L,. Definition and classification of early osteoarthritis of the knee. Knee Surg Sports Traumatol Arthrosc. 2012; 20 (3): 401-406.
24. Mandl LA, Losina E,. Relative efficacy of knee osteoarthritis treatments: are all placebos created equal? Ann Intern Med. 2015; 162 (1): 71-72.
25. Marcacci M, Filardo G, Kon E,. Treatment of cartilage lesions: what works and why? Injury. 2013; 44 (suppl 1): S11-S15.
26. Mariani E, Filardo G, Canella V,. Platelet-rich plasma affects bacterial growth in vitro. Cytotherapy. 2014; 16 (9): 1294-1304.
27. Mei-Dan O, Carmont MR, Laver L,. Platelet-rich plasma or hyaluronate in the management of osteochondral lesions of the talus. Am J Sports Med. 2012; 40 (3): 534-541.
28. Patel S, Dhillon MS, Aggarwal S, Marwaha N, Jain A,. Treatment with platelet-rich plasma is more effective than placebo for knee osteoarthritis: a prospective, double-blind, randomized trial. Am J Sports Med. 2013; 41 (2): 356-364.
29. Roffi A, Filardo G, Assirelli E,. Does platelet-rich plasma freeze-thawing influence growth factor release and their effects on chondrocytes and synoviocytes? Biomed Res Int. 2014; 2014: 692913.
30. Rutjes AW, Juni P, da Costa BR, Trelle S, Nuesch E, Reichenbach S,. Viscosupplementation for osteoarthritis of the knee: a systematic review and meta-analysis. Ann Intern Med. 2012; 157: 180-191.
31. Sánchez M, Fiz N, Azofra J,. A randomized clinical trial evaluating plasma rich in growth factors (PRGF-Endoret) versus hyaluronic acid in the short-term treatment of symptomatic knee osteoarthritis. Arthroscopy. 2012; 28 (8): 1070-1078.
32. Say F, Gürler D, Yener K,. Platelet-rich plasma injection is more effective than hyaluronic acid in the treatment of knee osteoarthritis. Acta Chir Orthop Traumatol Cech. 2013; 80 (4): 278-283.
33. Spaková T, Rosocha J, Lacko M, Harvanová D, Gharaibeh A,. Treatment of knee joint osteoarthritis with autologous platelet-rich plasma in comparison with hyaluronic acid. Am J Phys Med Rehabil. 2012; 91 (5): 411-417.
34. Torricelli P, Fini M, Filardo G,. Regenerative medicine for the treatment of musculoskeletal overuse injuries in competition horses. Int Orthop. 2011; 35 (10): 1569-1576.
35. Tschon M, Fini M, Giardino R,. Lights and shadows concerning platelet products for musculoskeletal regeneration. Front Biosci (Elite Ed). 2011; 3: 96-107.
36. Vaquerizo V, Plasencia MÁ Arribas I,. Comparison of intra-articular injections of plasma rich in growth factors (PRGF-Endoret) versus Durolane hyaluronic acid in the treatment of patients with symptomatic osteoarthritis: a randomized controlled trial. Arthroscopy. 2013; 29 (10): 1635-1643.
37. Zhu Y, Yuan M, Meng HY,. Basic science and clinical application of platelet-rich plasma for cartilage defects and osteoarthritis: a review. Osteoarthritis Cartilage. 2013; 21 (11): 1627-1637.